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Abstract. We have previously reported on the depen-
dency of activated B lymphocytes for retinol. Here we
confirm and extend these findings that cells deprived
of retinol perish in cell culture within days, displaying
neither signs of apoptosis nor of cell cycle arrest. Cell
death can be prevented by physiological concentrations
of retinol and retinal, but not by retinoic acid or three
synthetic retinoic acid analogues. To exclude the possi-
bility that retinoic acid is so rapidly degraded as to
escape detection, we have tested its stability in intra-
and extracellular compartments. Contrary to expecta-
tion, we find that retinoic acid persists for longer
(t,rz 3 d) in cultures than retinol (ti/2 1 d). Further-
more, despite the use of sensitive trace-labeling tech-
niques, we cannot detect retinoic acid or 3,4-didehy-
droretinoic acid among retinol metabolites. However,
retinol is converted into several new retinoids, one of
N higher vertebrates, nearly all tissues are bathed in a
constant supply of vitamin A, and the ubiquitous dis-
tribution of high-affinity intracellular retinoid-binding
proteins suggests that vitamin A is present inside most cells
(3, 7) . Whereas the specialized functions for retinol (e.g., in
vision) have been extensively investigated, a general meta-
bolic role for the molecule has not yet been determined (24,
25) . Retinol is not known to be incorporated into structural
parts of cells and no nuclear receptor for retinol has been
found. Hence its functional role is more likely as a precursor
for biological active derivatives, e.g., retinaldehyde in vision
(24), and retinoic acid as a morphogen (32) .
Although retinoic acid (32) and didehydroretinoic acid
(33) have critical functions in developmental biology, the
significance of ubiquitous presence of retinol in adult tissues
is not yet understood. On the other hand, among retinoids
that can enhance growth and induce differentiation, retinoic
acids are qualitatively and quantitatively more potent than
retinol or retinal (5, 13, 17, 30) . While the discovery of reti-
noic acid receptors (4, 15, 19) as transcriptional regulators
has provided a satisfactory explanation for the effectiveness
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which has the ability to sustain B cell growth in the
absence of an external source of retinol, supporting
the notion of a second retinol pathway. We have also
determined which of the known retinoid-binding pro-
teins are expressed in B lymphoblastoid cells. Accord-
ing to results obtained with polymerase chain reaction-
assisted mRNA detection, they transcribe the genes
for cellular retinol- and cellular retinoic acid-binding
proteins, for the nuclear retinoic acid receptors, RAR-
alpha, -gamma, and RXR-alpha, but not RARbeta.
Our findings that B cells do not synthesize retinoic
acid or respond to exogenous retinoic acid on the one
hand, but on the other hand convert retinol to a novel
bioactive form of retinol, suggest the existence of
a second retinoid pathway, distinct from that of reti-
noic acids.
of retinoic acids, the biological functions of retinol remain
unclear.
We have previously analyzed the growth requirements of
human lymphoblastoid cells in culture and have found that
these cells are critically dependent for growth on a constant
supply of retinol (6). In the absence of retinol, these cells
perish within days, and the addition of other retinoids, e.g.,
retinoic acid, are unable to prevent cell death. These findings
have prompted us to perform an analysis of retinoids in lym-
phocytes to investigate the hypothesis that retinoic acid is the
intracellular mediator for the retinol activity. We have nei-
ther been able to identify intracellular retinoic acid among
retinol metabolites, nor do we haveevidence that an extracel-
lular supply ofretinoic acid can overcome the retinol block.
However, we have identifiedtwo new retinoids in B lympho-
cytes. One of these is a substitute for retinol, and appears to
be an intracellular mediator of the control ofcell physiology
by retinol.
Materials and Methods
Retinoids
Ro 10-1670 (Etretine), Ro 13-7410 (TTNPB), Ro 40-6085 (AM 580), and
3,4-didehydroretinol were generous gifts of Hoffmann-LaRoche, Inc. (Nut-
851ley, NJ) . 3,4-didehydroretinol was oxidized to 3,4-didehydroretinal and 3,4-
didehydroretinoic acid according to the procedure of Mayer et al. (22).
Retinylesters were a gift of Dr. W. Blaner (Columbia University, New
York). All other unlabeled retinoids used were purchased from Sigma
Chemical Co. (St. Louis, MO). [3H]Retinol was purchased from Amer-
sham Chemical Co. (Arlington Heights, IL) and was >98 % pure according
to HPLC analysis. The retinoids were dissolved in methanol/chloroform
(3:1 vol/vol) at a concentration of 3 x 10-2 M with 10-° M butylated
hydroxytoluene (BHT)' (Sigma Chemical Co.) added and stored in the
dark at -20°C in a nitrogen atmosphere. Immediately before bioassays, the
stock solutions were diluted in serum-free medium.
CellLines
The human Epstein-Barr Virus (EBV)-transformed B-cell lines 5/2, Ducaf,
and SLA were established in our laboratory from the peripheral blood of
healthy donors. Thecell lines weregrown in RPMI 1640 supplemented with
8% FCS, t.-glutamine (2 mM), and antibiotics. The cell lines were tested
regularly for mycoplasma infections and were consistently negative. The
human teratocarcinoma cell lineN-tera 2, the human breast carcinoma line
BT20, the humanBurkitt lymphomacell line Raji, and the humanhepatoma
line Hep G-2 were obtained from the tumor cell line depository of Sloan-
Kettering Institute.
Cell Proliferation Assay
The assay system is a modification of the assay developed by Blazar et al.
(2). Cells taken fromtheir exponential growthphase were washed twice and
seeded with or without retinoids at gradedcell concentrations in serum-free
HB 101 medium (Hana Biologics, Berkeley, CA) or in FCS containing
RPMI medium. Assays were done in 96-well microtiter plates in a final vol-
ume of 200 gl/well or in 25-cm2 tissue-culture flasks. The cells in the mi-
crotiter plates were cultured for 72 h and cell growth was determined by
labeling for the last 16 h with 0.8 PCi of [3H]thymidine (6.7 Ci/mmol sp
act). Growth in the culture flasks was determined in three aliquots of 100
Pl taken at 24-h intervals and cultured in the presence of 0.8 wCi of
[3H]thymidine for an additional 6-h period. To determine the viable cell
number nine aliquots per time point were differentially counted in a Neu-
bauer chamber in the presence of trypan blue.
Retinoid Metabolism
Cells were washed and seeded at a density of 3 x 105 cells/ml in HB 101
medium. 10-6 M retinol or retinoic acid were added. In control experi-
ments, retinoids were added to culture medium alone. Aftervarious incuba-
tiontimes, 1-ml aliquots were removed, cells and conditioned medium sepa-
rated by centrifugation and immediately afterwards delipidated according
to the procedure of McLean et al. (23). In short, cell pellets suspended in
PBS or equal volumes of medium (0.8 ml) were extracted with 320 1AI of
n-butanol/acetonitrile (1:1 vol/vol) containing 10-° M BHT and 1.0 /Ag/ml
retinyl acetate as internal standard. The organic component was separated
by addition of 240 ul saturated K2HP04 and centrifugation for 1 min in an
Eppendorf centrifuge (Brinkmann Instruments, Westbury, NY). 150 wl of
the organic phase werechromatographed by HPLC (600 E solventdelivery
system and 991 photodiode array detector; Waters Associates, Milford,
MA) using an analytical reversed-phase C,8 HPLC column (Vydac; The
Separation Group, Hesperia, CA) . The eluate was acetonitrile/water
(80:20) containing 0.01 M ammonium acetate (flow rate 1.5 ml/min). Con-
centrations of extracted retinol and retinoic acid were quantitated by their
peak areas at 325 nm relative to the internal standard peak area and refer-
enced to standard curves of authentic retinol and retinoic acid.
Metabolites ofRetinol
Cells were washed and seeded at a density of6 x 106 cells in 10 ml of HB
101 medium with 1 t,Ci/ml [3H]retinol added. After 24 h, the washed cell
pellet was delipidated according to the described method of McLean et al.
(23). Unlabeled reference retinoids (1 wmeach) were added. The crude lipid
extract was loaded on an analytical reversed-phase C,8 column (Vydac) and
1. Abbreviations used in this paper: BHT, butylated hydroxytoluene;
CRABP, cellular retinoic acid binding protein; CRBP, cellular retinol bind-
ing protein; RAR, retinoic acid receptor; RBP, retinol binding protein;
RXR, retinoid X receptor.
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eluted with a gradient ofwater/methanol/chloroform as shown in Fig. 8. The
flowrate was0.5nil/min. The retention timesofthe referenceretinoids were
determined by theirspecific UVabsorption patterns in the photodiode array
detector. The radioactive elution pattern of [3H]retinol and its metabolites
was determined on line with a Flo 140 Radio-Chromatography Detector
(Radiomatic Instruments & Chemical Co., Tampa, FL) using 2.5 ml/min
Flo-scint V scintillation fluid (Radiomatic Instruments & Chemical Co.).
RNA and DNA Staining
To analyze cell progression through the cell cycle, cells were stained with
acridine orange (Polysciences, Inc., Warrington, PA) (9, 10). In brief, 0.4
ml of acid detergent (0.1% Triton X-100; 0.08 N HCI; 0.15 M NaCI) was
added to 0.2 ml of the cell suspension. 30 s later, 1.2 ml ofacridine orange
staining solution (6.0 kglml acridine orange, 10-3 M EDTA, 0.15 M NaCl,
0.1 M citrate-phosphate buffer at pH 6) was added to each sample. Cells
were measured immediatelyusing aFC200 flow cytometer (Ortho Diagnos-
tics, Westwood, MA) as described (18, 19). The red (600 to 640 run) and
green (515 to 575 run) luminescence emissions from each cell were opti-
cally separated, measured by separate photomultipliers, and the data col-
lected and stored in a Compaq Deskpro 386 computer. The number of cells
in Gl, S, and G2+M cell cycle compartments were calculated using inter-
active computer programs.
Pblymerase ChainReaction (PCR) Amplification
The following oligonucleotide primers were used: as upstream primer for
the human retinoic acid receptor (hRAR) alpha (15) RA 1: 5'-GCT TTG
TCT GTC AGG ACA AG-3; for hRAR beta (4) RA05: 5'-GGA GAA AGC
TCTCAA AGC ATG C-3' and for the RAR gamma (19) RA 5: 5'-AAGGAG
ATG GCC TCT CTG TC-3'. The oligonucleotide primer RA-2 : 5'-CCC
ACT TCA AAG CAC TTC TG-3' was used as downstream primer for all
three RARs, resulting in amplified products of 192 by (nucleotide position
365-557), 347 by (nucleotide 408-755), and 295 by (nucleotide 580-875)
for RAR a, ß, and -y, respectively. Oligonucleotide primer pairs RBPI (up-
stream) 5'-CTC TGG GAC CTG GTA CGC CA-3' and RBP2 (downstream)
5'-TTC TGG AGA AAG GAG GCT ACG-3' were used for the detection of
retinol-binding protein (RBP) (9). CRBPI (upstream) 5'-GGT ACT GGA
AGA TUT TGG TC-3' and CRBP2 (downstream): 5'-CTT GAA TAC TTG
CTT GCA GA-3' were used for the detection ofcellular retinol-binding pro-
tein (CRBP I) (8). These pairs forman amplified product of236 by (nucleo-
tide 436-837) for RBP and 376 by (nucleotide 145-521) for CRBP, respec-
tively. The oligonucleotide primers for the newly described nuclear retinoid
receptor RXR a (21) RXRI (upstream): 5'TCA ATG GCG TCC TCA AGG
TC-3' and RXR2 (downstream): 5'-ATG GCC AGG CAC TTC TGG TA-3'
form an amplified fragment of 255 by (nucleotide position 413-668). For
cellular retinoic acid-binding protein (CRABP) (35) a pair ofoligonucleo-
tide primers corresponding to the mouse sequence was used: CRABPI (up-
stream) 5'-TGG GAG AAT GAG AAC AAG AT3' and CRABP2 (down-
stream) 5'-ACC ACG TCA TCG GCG CCA AA-3, resulting in an amplified
product of 124 by (nucleotide position 69-193) .
Total RNA was extracted in a single-step procedure by using RNazol
(Cinna/Biotecx, Friendswood, TX). In a 20-pl reaction, 1 jug of total RNA
was reverse transcribed in 50 mM Tris HCl (pH 8.3), 75 mM KCI, 3 mM
MgC12, 10 mM DTT, 0.5 mM of each dNTP, 80 pmol oligo dT (15), 25 U
RNase inhibitor (Boehringer Mannheim, Indianapolis, IN) and 200 U of
MMLV reverse transcriptase (Bethesda Research Laboratories, Gaithers-
burg, MD). After incubation at 37°C for 1-2 h, the mixture was heated for
5 min at 95°C and 3 IA1 of lOx PCR-buffer (100 mM Tris-HCI (pH 8.3),
500 mM KCI, 20 mM MgCl2, 0.01% gelatin), 1.25 U of Taq DNA poly-
merase (Perkin Elmer-Cetus Corp., Emeryville, CA) and 50 pmol of each
primer was added and the volume adjusted to 50 t1. The reaction mixture
was overlaid with 45 tcl of mineral oil and then subjected to 35 cycles of
DNA amplification in a Perkin-Elmer thermocycler, using the following cy-
cle conditions: Denaturation for 1 min at 94°C, reannealing for 45 s at
55°C, extension for 1 min at 72°C. A final extension step for 7 min at 72°C
was added. Amplified products were analyzed by electrophoresis on a 1 .5%
agarose gel and visualized by ethidium bromide.
Results
Retinol Is a Stimulator ofCell Growth in Low
Serum-containing Medium
FCS is used in most cell culture systems at a concentration
852104-
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Figure 1. Effect of retinol on 5/2 cells in FCS containing medium .
Washed cells (2,500/well) were incubated with or without retinol
in RPMI medium with the indicated amount ofFCS . DNA synthe-
sis was measured by [ 3H]thymidine as described . The measure-
ments were done in triplicate . The SDs were <15% .
of5-10% . The growth rate of the 5/2 human lymphoblastoid
cell line decreases rapidly at serum concentrations <10%
(Fig . 1), as is the case with most cell lines . After 3 d of cul-
ture the 5/2 cells (25,000 cells/ml) in 1 .25% FCS containing
medium incorporated only one-twenty-fifth the [ 3H]thymi-
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dine of that incorporated in 10% FCS-containing medium .
At the optimal concentration of 10-6 M, retinol did not
change the thymidineuptake in 10% FCS but caused an eight-
fold increase in 1% FCS-containing medium . This growth-
enhancing effect of retinol was not limited to serum-contain-
ing medium but was also seen with serum-free medium (HB
101) as described previously (6) (see also Fig. 5) .
Cell Deathin Retinol-deficientMedium Is Cell Cycle
IndependentandIsNotApoptotic
The decrease in thymidine uptake in the retinol deficiency is
due to cell death (6 ; Fig . 2, A and B) . After 2 d of retinol
deprivation, 30%, and after 3 d, 90% of the 5/2 cells were
trypan blue positive. Cell death was not due to apoptosis (29,
36) since retinol-deficient 5/2 cells showed neither the degra-
dation ofDNA to oligonucleosomal bands nor the chromatin
condensation characteristic of apoptosis (data not shown) .
Retinol-deficient cells showed a disintegrating cytoplasm
with fused vacuoles when stained with Wright-Giemsa (Fig .
2, C and D) . The nuclei, with their nucleoli, remained intact
for prolonged periods of time . This observation was affirmed
by measuring theRNA and DNA contents of 5/2 cells grown
in retinol-deficient (Fig . 3 A) or retinol-containing medium
(Fig . 3 B) . 90% of cells from the retinol-deficient cultures
are contained in the boxed area, indicating that they had lost
most of their RNA due to disintegration of the cytoplasm .
Comparing the DNA content of the nuclei with that of the
normal cells showed similar distributions between G,, S,
and G2/M phases, suggesting that there was no preferential
cell death (loss ofcytoplasm) in any specific phase of the cell
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Figure 2. Retinol deprivation leads to cell
death . 5/2 cells were washed once and
seeded at a density of300,000/ml inHB 101
medium with and without 10-6M retinol .
The (A) trypan blue-negative and (B) try-
pan blue-positive cell number of nine ali-
quots was determined every 24 h . Means t
SDs are shown . In a repeat experiment cells
were stained with Wright-Giemsa stain af-
ter 40 h of culture. (C) Cells with 10-6M
retinol . (D) Cells without retinol .Y
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S/2Cells Ranscribe mRNAs SpecificforRetinoland
RetinoicAcid-binding Proteins
Requisite in retinoid physiology are the participation of
extra- and intracellular binding proteins. As a prelude to the
study of the pharmacological fate of retinol in B lymphoblas-
toid cells, we wished to take stock ofthe known cellular reti-
noid-binding proteins and therefore measured expression of
the respective messages. Using specific primers, cDNA was
amplified with the PCR and the expression of seven specific
mRNAs determined (Fig . 4). Using human genomic DNA
as template for DNA amplification, no primer pair leads to
the same PCR product as the amplified cDNAs (data not
shown) . This indicates that introns are within all the primer
pairs, as it is described for RBP, CRABP, and RAR (11, 12,
28). The cDNA detected by PCR reflects therefore exclu-
sively mRNA and is not compromised by genomic DNA
eventually present in the RNA preparation. In control PCR
experiments, we choseone cell line knownto be positive and
another negative for each particular mRNA . We were not
able to locate cell lines negative for RAR-a (Fig. 4 d) or
RXR-a (Fig. 4 g). 5/2 cells expressed mRNA for cellular
retinol-binding protein I (CRBP) (Fig . 4 a) and cellular reti-
noic acid-binding protein I (CRABP) (Fig. 4 b), but not for
serum retinol-binding protein (RBP) (Fig. 4 c) . There was
also message for the nuclear DNA binding proteins, RAR-a
(Fig. 4d), RAR-T (Fig. 4f), and RXR-a (Fig. 4 g), but no
transcript was detectable for RAR-ß in 5/2 cells (Fig. 4 e).
Dr. W Blaner confirméd by RNaseprotection assays that 5/2
cells are expressing mRNA for CRBP and CRABP and Dr.
W Miller (Memorial Sloan-Kettering Cancer Center) con-
2n
]ss
RNA content
￿
RNA content
Figure 3. Effect of retinol deprivation on RNA and DNA content. 5/2 cells were washed and seeded at a density of 50,000/ml in HB 101
(A) without, and (B) with 10-6 M retinol. After 48 h the cells were stained with acridine orange and 5,000 cells/sample were analyzed
by flow cytometer. Scattergrams represent distribution of cells with respect to their DNA and RNA content. 2n corresponds to diploid,
4n to tetraploid DNA content. The boxed dots with very low RNA content correspond to nuclei.
cycle (calculation not shown). The Burkitt lymphoma line
￿
firmed by Northern blotting expression of mRNA for RAR
Raji and two other EBVtransformed lines tested, showed the
￿
alpha and RXRalpha (personal communication).
same pattern of nonapoptotic, cell cycle-independent death
in retinol deficient medium (data not shown).
￿
Bioactivity ofNatural andSyntheticRetinoids
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Retinol is optimally bioactive at concentrations from 3 x
10-6 to 5 x 10-7 M in serum-free HB 101 medium (Fig. 5)
as well as in low serum containing medium (data not shown) .
Retinol is toxic to lymphoblastoid cells in serum-free or low
serum medium at concentrations >5 x 10-6 M. This tox-
icity can be prevented by increasing the amounts of serum
(data not shown) . Retinal is comparable with retinol in bio-
activity at a concentration range of 1.5 x 10-7 to 1.2 x
10-6 M, but is already toxic at 2 x 10-6 M (Fig. 5) . The bio-
activity of retinal is explicable by its fast conversionto reti-
nol by 5/2 cells. If 10-6 M retinal was given to 200,000 5/2
cells in HB 101 medium, 85 % of cellular and extracellular
retinal was converted to retinol in 30 min, and after 120 min
no retinal was detectable anymore (data not shown) . Reti-
noic acid, supposedly the most potent natural retinoid,
showed opposite effects at different concentrations (Fig. 5) .
At concentrations of 1 x 10-7 to 2 x 10-6 M, there is a sup-
pression of thymidine uptake. Between 5 and 8 x 10-6 M,
retinoic acid shows 10-70% of the retinol effect dependent
on the bioassay, and at 10-5 M retinoic acid is toxic. Retinyl-
palmitate does not show any bioactivity (data not shown). In
most cell differentiation studies in vitro (1, 31, 34) and in vivo
(13, 18), several synthetic retinoid analogs are up to 1000-
fold more active than retinoic acid. Retinol is usually unable
to induce differentiation. The three synthetic retinoic acid
analogues, Ro 10-1670 (Etretine), Ro 13-7410 (TTNPB),
and Ro 40-6085 (Am 580) (for chemical structure see Fig.
6 A) were tested for their growth-sustaining activity on 5/2
cells in comparison with the natural retinoids, all-trans reti-
nol and all-trans retinoic acid (Fig. 6 B). None ofthe deriva-
tives was able to replace retinol in the dose range testedFigure4 . Electrophoretic analysis ofamplifiedcDNA for (a) cellu-
lar retinal-binding protein (CRBP), (b) cellular retinoic acid-bind-
ing protein (CRABP), (c) retinal-binding protein (RBP), (d)
retinoic acid receptor alpha (hRAR), (e) beta (hRAR), (f) gamma
(hRAR), and (g) RXR, the newly described nuclear retinoid recep-
tor. 1 14g of total RNA extracted from (1) NTera-2 cells, (2) Hep
G-2 cells, (3) BT20 cells, and (4) 5/2 cells was reverse transcribed
and the cDNA amplified by using a specific oligonucleotide primer
pair.
between 10-9 and 10-6M . Ro 40-6055 and Ro 13-7410 pro-
duced an increase in thymidine uptake at a concentration of
1-3 X 10-7 M compared to the negative control, but this
effect was 8 to 20 times lower than the optimal response to
retinol . None of the derivatives at a concentration of 3 X
10-7M was able to reverse the decline in the thymidine up-
take on days 2 and 3 of culture (Fig . 6 C) due to cell death,
as described above. When the synthetic retinoids (at 3 X
10-7M concentration) were mixed with 10-6M retinol, the
growth stimulatory capacity of the latter was not inhibited
(Fig . 6 D) .
Retinol Is Used Up Faster in ConditionedMedium
than Retinoic Acid
It has been reported that forsome cells retinoic acid can rap-
Buck et al . Retinal and Retinoic Acid in B Lymphocytes
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Figure 5 Dose-response curves of different natural retinoids .
Washed 5/2 cells (5,000/well) were incubated for 72 h in HB 101
medium . The indicated amount of retinoids was added at the begin-
ning of the experiment (Ix) or added additionally after 24 and 48 h .
(3x) . DNA synthesis was measured by 1 3H)thymidine as described .
The measurements were done in triplicate . The SDs were <15% .
idly induce its own metabolism (26, 27) . Such rapid con-
sumption could explain the lack of bioactivity of retinoic acid
in lymphoblastoid cells . Therefore we tested the stability of
retinoids in 5/2 cell and Raji cell (data not shown) cultures
or cell-free "mock" cultures (Fig . 7) . We found that in the
presence of lymphoblastoid cells extracellular retinol con-
centrations decline more rapidly than those of retinoic acid .
The effective half-life of retinoic acid was ti3 d as compared
with 1 d for retinol . In the absence of cells, retinol and
retinoic acid proved equally stable, showing only an in-
significant difference in the rate of decline (15% and 30%,
respectively, over a 3-d period) .
To test for metabolites of retinol within cells, lympho-
blastoid cells were incubated overnight with tritium-labeled
retinol . The cells were harvested and delipidated . The crude
lipid mixture was separated on a reversed-phase column and
the eluting retinol and its metabolites compared to standard
concentrations ofreference retinoids . The most abundant in-
tracellular retinoid was all-trans retinol (45 min) . The
preceding shoulder at 44 min corresponds to 13-cis retinol .
The metabolites eluting between 66 and 78 min correspond
to retinylesters . The three major retinyl ester peaks coelute
with the standards for retinyl linoleate, retinyl oleate, and
retinylpalmitate, respectively. The cells contained two addi-
tional major groups ofmore hydrophilic retinol metabolites
with peak elution times of 32-35 min and 36-39 min . Both
peak regions contained more than one retinol metabolite
judged by the shape of the radioactive peaks . None of the
available retinol isomers or known metabolites, including
didehydroretinol and retinoic acid, elutes at these positions
in our analytical system . The corresponding retinoids thus
might comprise new forms of retinol metabolites . Peak
36-39 min has the same bioactivity on lymphoblastoid cells
as retinol (Table I) if fed daily to the cells . We failed to ob-
serve 3,4-didehydroretinol, retinoic acid, and 3,4-didehydro-C
O
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Figure7 . Rate of lossof retinol and retinoic acid in cell-conditioned
and unconditioned medium. 1 uM retinoid wasadded at zero time
toHB 101 medium containing no cells or 400,000/ml 5/2 cells . At
the showntime points aliquots of 1 nllwere taken, medium or con-
ditioned medium separatedby centrifugation from its cells, delipi-
dated, and analyzed on HPLC.
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retinoic acid at the expected positions . If conversion to reti-
noic acids occurs in lymphoblastoid cells, this must not
exceed 0.1% of the intracellular retinol .
Discussion
Figure 6. Retinol but not synthetic retinoic acid
analogs enable 5/2 cells to grow. (A)Chemical
structure ofretinoids used . (B) Dose-response
curves measured day 3 . (C) Effect of 3 x
10-7M retinoids measured day 1, 2, and 3 . (D)
Combination of retinoic acid analogues (3 x
10 -1 M) with (open bars) and without (filled
bars) 10~ M retinol measured day 3. In (B-D)
5/2 cells were washed twice and seeded at a
concentration of 150,000 cells/ml in HB 101
medium. Triplicate samples of 100 A1 of cell
suspension were removed daily andpulsed for
6 h with [3H]thymidine. Means are shown.
The SDs were never >20% .
In mammalianspeciesthemain formsofnaturally occurring
retinoids are retinol and its oxidation products, retinal and
retinoic acid and their cisltrans isomers . Retinoids enhance
growth andinduce differentiation inmany in vitroandin vivo
systems (5, 13, 17, 30) . In most instances, retinoic acids are
qualitatively and quantitatively more potent than retinol or
retinal . During studiesofgrowth controloflymphocytes, we
have shownpreviously (6) and confirmin the current report
that the reverseorderapplies to growth control, with retinol
and retinal more potent than retinoic acid, which is essen-
tially unable to supportB cell growth . Several closely related
nuclear receptors have been described for retinoic acid, but
none so far for retinol or retinal. The retinoic acid receptor
RAR with its three different subtypes (a, ß, and -y) (4, 15,0
￿
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Figure 8. Retinol metabolites in 5/2 cells. 5/2 cells (6 x 106 cells in 10 ml HB 101 medium) were incubated with all-trans-[3H]retinol
(10 tACi/ml). After 24 h, retinoids were extracted fromthe washed cell pellet and unlabeled marker retinoids were added. The crude mixture
was loaded on an analytical reversed-phase C,e column. Retinoids were eluted with the shown gradient of water/methanol/chloroform.
The flow rate was 0.5 ml/min. DPM were determined with an on-line scintillation counter. Reference retinoids were the all-trans forms
of 0, 3,4-didehydroretinoic acid; 1, all-trans-retinoic acid; 2, 3,4-didehydroretinol; 3, retinol; 4, retinyllinoleate; 5, retinyloleate; 6, retinyl-
palmitate.
19) as well as the newly described receptor RXR (21) are
retinoic acid inducible transcription factors of the ste-
roid/thyroid hormone receptor supergene family. Direct
binding of retinoic acid was shown for RAR but not for RXR
(21).
In this study, we used human lymphoblastoid cells as a
prototype for activated human B cells, but many other cell
types, including thymocytes and 3T3 cells show a similar de-
pendency on retinol (unpublished observation) . The prin-
cipal finding is that at a dilute cell density and below a certain
concentration of retinol these cells cease to grow and die.
The reason why they die is unclear. Cytological inspection
ofretinol-deprived lymphoblastoid cellsoffers few clues, ex-
cept that events seem to develop in the cytoplasm, which
eventually lyses, leaving intact nuclei behind. Thus apopto-
sis is precluded, and we have confirmed that the characteris-
Table I. Comparison ofGrowth-stimulating Effect between
Retinol and the Retinol Derivative Peak 36-39 min
Stimulating agent
￿
Growth-stimulating effect
cpm
Plain medium
￿
362 t 193
Retinol (10-6 M)
￿
38,645 t 4,357
Peak 36-39 min
￿
31,421 f 3,713
Washed 5/2 cells (5,000/well) were incubated for 72 h in serum-free HB101
medium. DNA synthesis was assessed by a 16-h ['H]thymidine uptake. The
experiment was done in triplicate. The data correspond to mean t SD. Peak
36-39 min was prepared according to the following procedure: 2,000 nil of5/2
cells (600,000/ml) were grown with 10- 1 M retinol added to HB101 medium.
After 16 h, retinoids were eluted from the washed cell pellet. The crude mix-
ture was loaded onto a semipreparative reversed-phase C18 column. Retinoids
were eluted with the gradient of water/methanol/chloroform shown in Fig. 8.
The flow rate was 2 ml/min. The peak corresponding to 36-39 min was co-
eluted and used 1/100 in the illustrated experiment. The retinoids were refed
daily.
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tic "ladder" of oligonucleosomal bands is not seen in agarose
gels (29, 36). Analysis of the total DNA content of nuclei
by flow cytometry informs us that they derived from cells
with a distribution from diploid to tetraploid, similar to that
of intact cells of an exponentially growing culture. Hence,
a blockage in any particular phase of the division cycle in
retinol-deprived cells is unlikely to contribute to cell death.
It is unclear why lymphoblastoid cells at high density (>1( 5/
ml) survive retinol starvation apparently intact. However,
when such high-density, retinol-deprived cells are trans-
ferred to low density, retinol-free conditions, cell deathis ac-
celerated. It is conceivable that intracellular stores of vita-
min A in the form of retinylesters are used up, rendering the
cells even more sensitive to retinol deprivation.
Dose-response relationships in retinol stimulation show
that conditions comparable to physiological ones are at-
tained in cell culture. The normal concentrations of retinol
in human and bovine plasma is 1.0-1 .5 x 10-6 M (16), and
10-6-10-' M was the optimal range required by cells in
serum-free medium. Most frequently used media formula-
tions contain 10% FCS, corresponding to a retinol concen-
tration of 10-' M, and interestingly 10-' M retinol is also a
concentration sustaining growth in serum-low or serum-free
medium, provided that it is replenished daily. The need for
repeated feeding may be due to the different forms in which
retinol is delivered to cells, i.e., as a stable complex with the
serum protein RBP in FBS-containing serum versus a semi-
stable complex with albumin in serum-free medium.
Our survey of proteins concerned with retinoid transport,
storage, and function showed mRNÀs of several of them ex-
pressed in 5/2 cells. The use of oligo dT to prime reverse
transcription and the sizes of the PCR products observed
indicate that only fully transcribed, polyadenylated and pro-
cessed mRNA is amplified by the PCR. 5/2 cells express
message for CRBP and CRABR CRBP is thought to play aspecific role in cellular uptake of retinol (7) . The role of
CRABP in lymphoblastoid or other cells is unclear. This
protein has high affinity for retinoic acid and its synthetic an-
alogues TTNPB, AM80, and Etretine, and none for retinol
(18) . The presence ofCRABP poses the question of its func-
tion in cells that have not been found to produce measurable
levels of retinoic acid . In other systems retinoic acid has been
found to originate from cells different from those which re-
spond to it . The role of retinoic acid, providing directly or
indirectly positional information to developing cells in the
chick wing bud is one pertinent example (32) . The proposed
role ofCRABP in this system is to modulate the morphogen
gradient (20) . Lymphoblastoid cells, however, are not
known to depend on retinoic acid, yet they express specific
binding protein . Similar puzzles concern the retinoic acid
receptors RAR alpha and gamma, as well as RXR, whose
mRNAs are expressed in 5/2 cells. In the absence of measur-
able amounts of retinoic acid, and assuming that retinoic
acid is indeed the natural ligand for each, their functional
potential in lymphoblastoid cells is unclear .
As mentioned before, in most biological test systems for
retinoids employed to date, especially those measuring the
differentiation potential, retinoic acid is superior in potency
to retinol (5, 13, 17, 30) . In fact, in some systems retinol ap-
pears to be completely inactive . Retinoic acid analogues, es-
pecially TTNPB, are more potent inducers of differentiation
than retinoic acid itself (1, 13, 18, 31, 34) . TTNPB induces
transcriptional activity of RAR but not of RXR (21), In the
context of our investigation on growth promotion by reti-
noids, it is noteworthy thatretinoic acid and its synthetic ana-
logues are inactive despite the presence ofthe corresponding
cytoplasmic and nuclear receptors thought to mediate reti-
noic acid effects . Retinoic acid does not impede the action
of retinol, as mixtures of the two exhibit the same dose-
dependent growth stimulation as retinol alone .
Retinoic acid, but not retinol, has been shown in hamster
tissues and a number of cell lines to induce its own catabo-
lism (25, 27) . It has been argued that IOTl/2 cells fail to un-
dergo transformation in response to retinoic acid because it
is more rapidly cleared and degraded than retinol (27) . It has
been further proposed that retinol would constitute the reser-
voir from which a constant supply ofshort-lived retinoic acid
would be produced . Rapid turnover would explain why so lit-
tle retinoic acid can be detected . We have tested this hypoth-
esis in 5/2 and Raji cells and find that it does not apply. On
the contrary, in these cell lines retinol, with a t1/2 Of I d, is
metabolized faster than retinoic acid (t,12 , 3 d) . Thus, insta-
bility cannot be the explanation for the lack ofgrowth stimu-
lation by retinoic acid .
We also investigated whether lymphoblastoid cells are
able to convert retinol to retinoic acid or didehydroretinoic
acid, by using radioisotope-labeled all-trans-retinol . With-
in the limits of the sensitivity of our assay procedure, esti-
mated to be able to detect levels as low as 10-9 M, we were
unable to detect retinoic acid or didehydroretinoic acid . In-
stead, we found relatively large amounts of retinylesters and
twonew retinoids at elution times 32-35 min and 36-39 min .
Judged by spectral criteria and the isotope content, these two
hitherto unidentified compounds are likely to bemembers of
the family of retinoids . We speculate that one of them, elut-
ing at 36-39 min, may constitute the intracellular mediator
of retinol . We base this possibility on the observation that
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among the retinol metabolites detected in 5/2 cells, solely
the 36-39-min peak contained the activity to sustain retinol-
deprived 5/2 cells in culture . Experiments are in progress to
assess whether this novel retinoid exerts its growth-control-
ling effects via one of the "orphan" receptors (14) of the ste-
roid/retinoic acid receptor superfamily.
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